The North American biguanide drugs market, projected at $1.36 billion in 2025, is experiencing steady growth driven by rising type 2 and gestational diabetes prevalence. Discover key market trends, leading companies (Metformin, type 2 diabetes medication), and future forecasts in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.